The main drug industry lobbying group on Tuesday said that it had "serious concerns" with major elements of President Trump's new plan to bring down drug prices.
The main drug industry lobbying group on Tuesday said that it had "serious concerns" with major elements of President Trump's new plan to bring down drug prices.